Drug giants' merger collapse set to hit shares

1998-02-25T00:00:00

The two pharmaceutical giants represent about 8% of the FT-SE 100 and have been responsible for a 15% rise in the index since the merger was announced on 30 January. Their planned get-together gave confidence to merger speculation in the financial sector to push blue-chips shares to a record ...

Keep reading this article by becoming a FlightGlobal member now

PLEASE REGISTER FOR FREE OR SIGN IN TO CONTINUE READING

You have reached your limit of free articles for this period. Register for a FREE account to read this article and benefit from:

Increased access to online news and in-depth articles from:
FlightGlobal Premium covering the global aviation industry
Airline Business providing insight for business leaders
Weekly newsletters on topics across the industry

Join now